Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 311

    1.

    The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.

    Ametov AS, Barinov A, Dyck PJ, Hermann R, Kozlova N, Litchy WJ, Low PA, Nehrdich D, Novosadova M, O'Brien PC, Reljanovic M, Samigullin R, Schuette K, Strokov I, Tritschler HJ, Wessel K, Yakhno N, Ziegler D; SYDNEY Trial Study Group.

    Diabetes Care. 2003 Mar;26(3):770-6. Erratum in: Diabetes Care. 2003 Jul;26(7):2227. PMID: 12610036 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.

    Ziegler D, Hanefeld M, Ruhnau KJ, Hasche H, Lobisch M, Schütte K, Kerum G, Malessa R.

    Diabetes Care. 1999 Aug;22(8):1296-301.PMID: 10480774 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.

    Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, Munzel U, Yakhno N, Raz I, Novosadova M, Maus J, Samigullin R.

    Diabetes Care. 2006 Nov;29(11):2365-70.PMID: 17065669 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis.

    Ziegler D, Nowak H, Kempler P, Vargha P, Low PA.

    Diabet Med. 2004 Feb;21(2):114-21.PMID: 14984445 [PubMed - indexed for MEDLINE]Related articles

    5.

    Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study).

    Ziegler D, Hanefeld M, Ruhnau KJ, Meissner HP, Lobisch M, Schütte K, Gries FA.

    Diabetologia. 1995 Dec;38(12):1425-33.PMID: 8786016 [PubMed - indexed for MEDLINE]Related articles

    6.

    Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy.

    Reljanovic M, Reichel G, Rett K, Lobisch M, Schuette K, Möller W, Tritschler HJ, Mehnert H.

    Free Radic Res. 1999 Sep;31(3):171-9.PMID: 10499773 [PubMed - indexed for MEDLINE]Related articles

    7.

    Clinical experience with thioctacid (thioctic acid) in the treatment of distal symmetric polyneuropathy in Korean diabetic patients.

    Hahm JR, Kim BJ, Kim KW.

    J Diabetes Complications. 2004 Mar-Apr;18(2):79-85.PMID: 15120701 [PubMed - indexed for MEDLINE]Related articles

    8.

    Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review.

    Ziegler D.

    Treat Endocrinol. 2004;3(3):173-89. Review.PMID: 16026113 [PubMed - indexed for MEDLINE]Related articles

    9.

    Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group.

    Apfel SC, Schwartz S, Adornato BT, Freeman R, Biton V, Rendell M, Vinik A, Giuliani M, Stevens JC, Barbano R, Dyck PJ.

    JAMA. 2000 Nov 1;284(17):2215-21.PMID: 11056593 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy.

    Ruhnau KJ, Meissner HP, Finn JR, Reljanovic M, Lobisch M, Schütte K, Nehrdich D, Tritschler HJ, Mehnert H, Ziegler D.

    Diabet Med. 1999 Dec;16(12):1040-3.PMID: 10656234 [PubMed - indexed for MEDLINE]Related articles

    11.

    Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy.

    Ziegler D, Gries FA.

    Diabetes. 1997 Sep;46 Suppl 2:S62-6. Review.PMID: 9285502 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Curative effect of alpha-lipoic acid on peripheral neuropathy in type 2 diabetes: a clinical study]

    Liu F, Zhang Y, Yang M, Liu B, Shen YD, Jia WP, Xiang KS.

    Zhonghua Yi Xue Za Zhi. 2007 Oct 16;87(38):2706-9. Chinese. PMID: 18167250 [PubMed - indexed for MEDLINE]Related articles

    14.

    Alpha-lipoic acid in the treatment of autonomic diabetic neuropathy (controlled, randomized, open-label study).

    Tankova T, Koev D, Dakovska L.

    Rom J Intern Med. 2004;42(2):457-64.PMID: 15529636 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Predictors of alpha-lipoic acid treatment efficacy in diabetic polyneuropathy of the lower limbs]

    Bregovskiĭ VB, Posokhina OV, Karpova IA.

    Ter Arkh. 2005;77(10):15-9. Russian. PMID: 16320678 [PubMed - indexed for MEDLINE]Related articles

    16.

    Treatment of symptomatic polyneuropathy with actovegin in type 2 diabetic patients.

    Ziegler D, Movsesyan L, Mankovsky B, Gurieva I, Abylaiuly Z, Strokov I.

    Diabetes Care. 2009 Aug;32(8):1479-84. Epub 2009 May 26.PMID: 19470838 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Efficacy and safety of alpha-lipoic acid supplementation in the treatment of symptomatic diabetic neuropathy.

    Foster TS.

    Diabetes Educ. 2007 Jan-Feb;33(1):111-7.PMID: 17272797 [PubMed - indexed for MEDLINE]Related articles

    19.

    Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials.

    Ziegler D, Reljanovic M, Mehnert H, Gries FA.

    Exp Clin Endocrinol Diabetes. 1999;107(7):421-30. Review.PMID: 10595592 [PubMed - indexed for MEDLINE]Related articles

    20.

    Monotonicity of nerve tests in diabetes: subclinical nerve dysfunction precedes diagnosis of polyneuropathy.

    Dyck PJ, O'Brien PC, Litchy WJ, Harper CM, Klein CJ, Dyck PJ.

    Diabetes Care. 2005 Sep;28(9):2192-200.PMID: 16123489 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data